Cryptosporidium sp. causes fulminant diarrhea and chronic infection in immunocompromised, particularly human immunodeficiency virus-infected, persons. The lack of in vitro cultivation and a suitable animal model has limited development of effective treatment. We describe two new mouse models of chronic symptomatic cryptosporidiosis in adult athymic mice and in T-cell subset-depleted mice. A progressive infection, fatal within 4 months, occurred in most adult athymic mice; a few developed stable infections. Symptoms included dehydration, weight loss, intermittent diarrhea, and jaundice. Pathologic abnormalities and organisms localized in the intestine in stable infections but involved the hepatobiliary tree and pancreas in others. Lymphoid cells from histocompatible, Cryptosporidium sp.-immune mice cured infected nude mice. Identical infections occurred in neonatally infected BALB/c mice treated with anti-CD4 monoclonal antibodies alone or also with anti-CD8 monoclonal antibodies; the mice were cured when the monoclonal antibody treatments were stopped. These models will be useful in definition of the immune defects that permit chronic cryptosporidiosis to develop and in assessment of treatment modalities.
Cryptosporidium infection is now a well-recognized cause of diarrhea in immunologically healthy and compromised humans and in animals of veterinary and agriculture interest throughout the world (4, 11, 33) . Clinical disease can be fulminant, particularly in human immunodeficiency virus (HIV)-infected hosts, in whom infection persists throughout life. While immunologically healthy patients recover spontaneously within 30 days, their clinical illness can also be severe and their potential for transmission can be persistent for as long as 60 days after symptoms cease (9, 18, 34) . Treatment remains limited to hydration and hyperalimentation although more than 90 interventional agents have been tried (4, 11, 33) .
By 1986, in the United States, an estimated 3.6% of HIV-infected individuals reported to the Centers for Disease Control, Atlanta, Ga., had cryptosporidiosis (24) . In patients with acquired immunodeficiency syndrome and diarrhea, 15% of those evaluated at the National Institutes of Health, Bethesda, Md., and 16% of those evaluated at the Johns Hopkins Hospital, Baltimore, Md., had cryptosporidiosis, which was the most common pathogen in the latter series (21, 32) . In two hospitals in Great Britain and Brazil, respectively, 11 and 12% of patients with acquired immunodeficiency syndrome were infected with Cryptosporidium sp. and 19% of those in Great Britain were thought to have died as a direct result (3, 8) . In other populations, Cryptosporidium infection has been described in at least 50 countries throughout the world and is thought to be one of the top enteropathogens in many regions of the less-developed world. Symptomatic illness occurs most often in children and is prolonged by concomitant immunosuppressing conditions, such as malnutrition (4, 11) .
The lack of a simple in vitro cultivation system and the lack of a suitable small animal model have limited more rapid development and testing of treatment modalities as well as better understanding of the immunologic response to this parasite (5, 6) . We describe here two mouse models of * Corresponding author. chronic symptomatic cryptosporidiosis, one in adult congenitally athymic nude mice and the other in anti-CD8 (antiLyt2) and/or anti-CD4 (anti-L3T4) antibody-treated suckling BALB/c mice. These models offer the opportunity to investigate therapeutic and immunologic modulation of this infection, as well as to study the specific immune defects which permit prolonged Cryptosporidium infection in some hosts.
MATERIALS AND METHODS
Cryptosporidium oocyst preparation. Cryptosporidium parvum oocysts were purified from feces of orally infected newborn calves (from two geographically distinct areas) by flotation in distilled water saturated with sodium chloride, followed by three washes in distilled water and, finally, by sedimentation in phosphate-buffered saline (pH 7.4) (38 In two other temporally unrelated experiments, neonatal BALB/c mice were fed approximately 107 oocysts on days 3 and 5 of life through an 18-gauge needle covered with silicone rubber tubing (2.1-mm peristaltic pump tubing; Pharmacia Biotechnology, Piscataway, N.J.) inserted into the oral cavity. All litters were housed with their dams as described above until natural weaning occurred; no prophylactic antibiotics were administered. By 7 to 10 days of life, all neonates produced formed stools, and both fecal examination and clinical observations were performed as described below.
Fecal examination and clinical assessment. Fecal pellets from each mouse were examined for Cryptosporidium oocysts before feedings and at least four times per week thereafter. Each animal was assessed clinically on days of stool collection for lethargy, weight loss, skin turgor, skin coloration, and abdominal distention. Stool consistency was also noted. Five adult-size fecal pellets were collected from each adult mouse, homogenized in 1 ml of distilled water, mixed with 8 ml of Sheather sucrose solution, and centrifuged at 850 x g at 4°C for 10 min to concentrate oocysts. Approximately half a suckling mouse-size fecal pellet was obtained from each neonatal mouse and homogenized with an equal amount of Sheather sucrose solution. The number of oocysts in a single drop of the resulting mixture was determined by direct light microscopic examination of 25 (neonatal mice) or 100 (adult mice) microscopic fields (45 x objective). These procedures for enumerating oocysts by fecal examination are useful for comparisons among different experimental animal groups. Oocysts were recognized by their typical pink refringence (1); selected specimens were confirmed by modified acid-fast staining.
Monoclonal antibody preparation. The hybridomas GK1.5 (40) and 2.43 (29) , which produce rat immunoglobulin G2b (IgG2b) monoclonal antibodies to murine T-cell CD4 and CD8 determinants, respectively, were grown in ascitic fluid in pristane-primed nude mice. The rat IgG2b fractions were purified from these ascites fluids by sequential (NH4)2SO4 precipitation, DE-52 ion-exchange chromatography, and Sephadex G-200 gel filtration, as previously described (12) . The same procedure was used to purify the IgG fraction of nonimmune rat serum (Pel-Freez, Rogers, Ark.). The purified antibodies were concentrated by ultrafiltration through a Dia-Flo PM-10 membrane (Amicon Corp., Danvers, Mass.) and were dialyzed against 0.15 M NaCl and kept at -70°C until use.
Microbiologic and pathologic examination. Animals were euthanized by lethal overexposure either to methoxyflurane or carbon dioxide. At euthanasia, 1 to 2 ml of whole blood was collected by sterile intracardiac puncture. Serum was separated by centrifugation and analyzed for antibodies to the following murine pathogens: minute virus of mice, pneumonia virus of mice, reovirus type 3, mouse hepatitis virus, K virus, Theiler's virus, Sendai virus, lymphocytic choriomeningitis virus, mouse adenovirus, ectromelia virus, polyomavirus, and Mycoplasma pulmonis (Anmed/Biosafe, Rockville, Md.).
At necropsy, the contents of the stomach, duodenum, ileum, jejunum, cecum, colon, and gallbladder were aspirated with needle and syringe. The contents were mixed with an equal amount of Sheather sucrose solution, and a single drop was examined for Cryptosporidium oocysts by direct microscopy (magnification, x45). A complete gross examination of all organs and tissues was conducted, and any visible abnormalities were noted. Pieces of liver for culture were collected by using sterile technique, emulsified in Trypticase soy broth, and plated on blood agar, MacConkey agar, and thioglycolate medium. All major organs and tissues were collected and placed in 10% buffered Formalin for fixation. The tissues were then embedded in paraffin for routine histopathologic processing. Sections were stained with hematoxylin and eosin and examined with a bright-field microscope.
RESULTS
Chronic, severe Cryptosporidium infection can be established in adult nude mice. Initial experiments were performed to determine whether adult nude mice could be infected with Cryptosporidium parvum and, if so, to determine the duration and consequences of such an infection. A total of 14 mice, age 6 to 10 weeks, were infected as described above. No significant clinical abnormalities were observed in any mouse for the first 3 weeks after infection. Subsequently, dehydration, weight loss, and poor skin turgor with dry, flaky skin occurred, accompanied by intermittent loose, bulky and often frankly diarrhetic stools, with large amounts of fecal fat visible microscopically. All infected animals exhibited these clinical signs alternating with periods of normality. Three distinct patterns emerged. The first was characterized in four mice by an abrupt exacerbation of clinical illness over a 2 to 3-day period, followed by death. Two mice, including one with frank jaundice, had a gradual decline over a 4-week period, also followed by death. A final group of three mice continued in a steady state of Cryptosporidium infection until sacrificed at week 16 after inoculation. The five other mice died from causes unrelated to cryptosporidiosis, from massive aspiration during feeding or esophageal penetration and abscess formation subsequent to feeding.
No animal shed more than 10 oocysts per microscopic field during the first 3 weeks after infection (Fig. 1) . Subsequently, the numbers of oocysts shed increased to as many as 80 per microscopic field. This did not correlate with clinical manifestations, except on the day or two before death, when the numbers decreased significantly. All mice shed oocysts on every day of fecal examination although the number detectable varied considerably from day to day, as is characteristic of Cryptosporidium oocyst shedding; the weekly standard deviation was usually equal to the mean number of oocysts shed weekly.
Complete necropsy was possible on nine mice from different clinical groups. On gross pathologic inspection, those mice that had appeared most ill were frequently icteric, were emaciated with abdominal distention, and demonstrated hepatomegaly and dilated biliary systems. The livers of some of these mice showed a diffuse reticular pattern representing the inflamed intrahepatic biliary system and portal areas (Fig. 2B) ; the common bile ducts, cystic ducts, gallbladders, and extrahepatic ducts were distended and often had opaque and thickened inflamed walls (Fig. 2B ). Blood from bleeding gastric ulcers filled the small intestine in some instances. Clinically stable mice that were sacrificed at 16 weeks demonstrated none of these findings ( Fig. 2A) .
On histologic examination, most infected animals, irrespective of clinical picture, showed mild to moderate gastric ulceration, inflammation at the pyloric ring, typhlitis, colitis, and splenic and mesenteric lymphoid hyperplasia. The mice with more severe clinical deterioration had the greatest inflammation of the gallbladder and biliary tree, the liver, and the pancreas (Fig. 2B, 3A and B, and 4A and B). In general, intestinal inflammation associated with Cryptosporidium sp. was characterized by degeneration, sloughing, and regeneration of both surface and glandular epithelial cells and dilated crypts and glands. Inflammation of the liver (Fig. 3A and B ) centered on bile ducts, portal and periportal areas, with associated hepatocyte degeneration and necrosis; fibrosis and striking biliary hyperplasia were present in portal areas, and inflammation often bridged portal areas. Choledochitis, cholecystitis, and cholangitis were indicated by hyperplasia, dilatation, chronic-active inflammation, and occasional erosions. The pancreas displayed necrosis with atrophy, infiltration by inflammatory cells, and hyperplastic ducts ( Fig. 4A and B and mesenteric lymph nodes of five BALB/c mice that spontaneously recovered after neonatal Cryptosporidium infection.
All immunologically reconstituted mice cleared detectable Cryptosporidium organisms within 1 week of injection of immune lymphoid cells ( Table 2 ). The experiment was terminated once the injected mice had not shed oocysts for at least 28 days. Necropsies performed on two of these mice at 8 weeks after the initial infection detected no gross lesions; histopathology detected no Cryptosporidium organisms. At week 25, the two remaining reconstituted mice continued to have no detectable oocyst shedding. In contrast, one mouse of the nonreconstituted group died after a period of gradual clinical deterioration at 16 weeks (Cryptosporidium organisms were found in aspirates taken throughout the small and large intestines) and two other nonreconstituted mice continued to shed organisms and show clinical disease progression. Chronic Cryptosporidium infection can be produced in neonatally infected mice that are treated with anti-CD4 or anti-CD4 plus anti-CD8 antibodies. To determine whether suppression of T-cell function prolongs Cryptosporidium infection, BALB/c mice that had been infected with Cryptosporidium sp. as neonates received either no additional treatment (n = 11) or weekly intraperitoneal injections of 0.5 mg each of monoclonal anti-CD4 plus anti-CD8 antibodies, beginning on day 5 of life (n = 4). (This dosage of monoclonal antibody eliminates CD4' T cells [20] ). While mice that did not receive anti-T-cell antibodies became free of evident infection 3 to 5 weeks after inoculation, mice treated with anti-T-cell antibodies continued to excrete oocysts throughout the period of antibody administration. Two of the latter mice, in which antibody administration was discontinued 6 weeks after Cryptosporidium inoculation, stopped shedding oocysts by week 8. One of these two was necropsied 10 weeks later and showed no evidence of remaining infection. Of the two mice continuously treated with anti-T-cell antibody, one developed a clinical picture similar to that noted in the severely ill infected nude mice and died 7 weeks after inoculation. The other continued to receive weekly anti-T-cell antibodies for 20 weeks after Cryptosporidium inoculation, at which time it was sacrificed; at necropsy, findings included diffusely lociated Cryptosporidium organisms throughout the intestinal tract with inflammation in the pyloric area, colitis, and splenic and mesenteric node hyperplasia.
An additional experiment was performed in which neonatally infected mice received anti-CD4 monoclonal antibody alone, both anti-CD4 and anti-CD8 monoclonal antibodies, anti-CD8 monoclonal antibody alone, normal rat IgG, or no antibody ( Table 3 ). Mice that received no antibody, normal rat IgG, or anti-CD8 monoclonal antibody alone ceased shedding detectable oocysts by 3 or 4 weeks after inoculation; in contrast, mice treated with anti-CD4 monoclonal antibody or with a combination of anti-CD4 plus anti-CD8 monoclonal antibodies continued to shed oocysts for the duration of antibody treatment and for 2 to 4 additional weeks after antibody treatment was stopped. One mouse that received both anti-CD4 and anti-CD8 antibodies was sacrificed at week 5 areas. Two anti-CD4 antibody-treated animals that were sacrificed 5 weeks after antibody treatment had been stopped had no detectable organisms in their intestinal contents.
DISCUSSION
Cryptosporidiium infection was first noted in 1907 by E. E. Tyzzer as an asymptomatic infection in the gastric glands of laboratory mice (C. muris); a second isolate (C. parvum) was subsequently identified in the small intestinal epithelia of laboratory mice (36, 37 9 days, and that oocysts are spontaneously cleared by 3 weeks of age (7, 10, 16) .
Attempts to infect adult mice include the establishment of intrauterine infection by direct inoculation (22) and the establishment of intestinal (particularly in the ileum, upper colon, and cecum) infection in germfree adult mice (14) , although infection in these adults was never as great as in suckling mice inoculated and sacrificed at the same time as the adult mice.
In nude mice, experimentally infected neonatal animals were reported to develop a chronic infection in which diarrhea, dehydration, weight loss, and increased oocyst shedding were observed approximately 30 days after infection (16) . Cryptosporidium organisms were found in the ilea, ceca, and colons of these mice. In contrast, the same authors reported that 42-day-old adult athymic nude mice shed only an occasional oocyst during the 11 days they were monitored with fecal examination postinfection with Cryptosporidium sp. (16) . In another study, only 1 of 28 nude mice more than 21 days old became intestinally infected as determined by histologic examination (31) . In both of these studies, although mice (of necessity, since systematic in vitro cultivation of Cryptosporidium sp. is not possible) received oocysts purified from fecal specimens as did the animals discussed here, the inoculum size and method of administration of oocysts were different.
Rat models which rely on the administration of hydrocorti- (2, 25, 26) . The mouse models described here have advantages over these earlier models and also further elucidate immune requirements for the control of Cryptosporidium infection. Chronic symptomatic cryptosporidiosis of the gastrointestinal and hepatobiliary tracts can be produced in adult (rather than neonatal) athymic mice and in infant mice as they mature by depletion of CD4+ T-cell function. Monitoring of clinical signs and serial study of formed feces for oocyst excretion are possible for longer periods of time, which allows the course of the disease to be better delineated and avoids reliance on a single necropsy examination, which characterized some other studies. Anti-CD4 antibody also modifies the immune system in a way that more closely resembles the selective CD4+ T-cell deficiency in HIV infection than does steroid or cytoxic drug treatment or even the pan-T-cell defect of nude mice. This depletion prevents the spontaneous clearing of Cryptosporidium organisms that characteristically occurs as otherwise-untreated, neonatally infected mice mature and points to specific T-cell defects which allowed chronic cryptosporidiosis to develop. This should permit testing of possible therapeutic interventions in a system that more closely resembles (although is not identical to) the human HIV-infected patient with chronic cryptosporidiosis.
In HIV-infected patients, symptoms fluctuate, with asymptomatic periods alternating with modest or more intractable diarrhea (4, 11, 18, 33, 34) . Histologically documented extraintestinal cryptosporidiosis and associated symptoms in these patients have been increasingly reported, particularly involving the biliary tract. Acalculous cholecystitis, cholangitis, portal hepatitis, hepatic pericholangitis, and pancreatitis have all been described, occasionally, in immunocompetent individuals as well (13, 15, 19, 23, 30) . Of note, concentrated searches for Cryptosporidium life cycle stages outside the intestinal tract are still rudimentary in humans.
Both the infected congenitally athymic mice and the neonatally infected, persistently anti-CD4 antibody-treated BALB/c mice also developed waxing and waning periods of diarrhea, with increasing weight loss and dehydration, that began about 4 weeks after oral inoculation. Rapid deterioration or a more slowly progressive illness preceded death in many immunodeficient mice, while others developed a steady clinical state that persisted until termination of the experiment. This result has not been described in any other small animal model to date, most of which produce asymptomatic or intestinally limited infections or require the use of broadly immunosuppressive agents, such as cyclophosphamide or hydrocortisone acetate (2, 10, 16, 25, 26, 31) . Oocyst shedding also varies in most infected humans on a daily and weekly basis, as it does in the mouse models described here (18, 34) .
Necropsy examination of chronically infected animals confirms diffuse infection with Cryptosporidium organisms comparable to that of some HIV-infected humans. Most mice showed organisms in the intestine, and unlike humans, at the pyloric ring, while those with the most severe clinical illness had involvement of the pancreas and hepatobiliary tree. Although the simultaneous presence of another undetected pathogen or a necessary cofactor cannot absolutely be ruled out either in these mice or in humans, all viral serologic studies and liver cultures that were performed on mice in our study were negative, and there was no histopathologic evidence of other infectious agents.
Our observations about the importance of CD4+ T cells in the control of Cryptosporidium infection are consistent with findings for closely related parasites: nude BALB/c mice maintain stable infections with Giardia muris unless reconstituted with lymphoid cells, particularly those from mice previously exposed to Giardia sp., while normal mice have self-limited infection (27, 35) . Monoclonal antibody studies have shown that CD4+ T cells are necessary for elimination of G. muris, although CD8+ T cells are not (17) . CD4+ T cells also mediate immunity to the related coccidian Eimeria vermiformis in mice (28) , and selective depletion of these lymphocytes, also in a murine model, leads to death from overwhelming infection with Toxoplasma gondii, another related coccidian parasite (39) .
Our studies indicate that Cryptosporidium infection is easily established in adult nude mice, as was previously reported for neonatal nude mice (16) . Surprisingly, this is not the case for anti-CD4 antibody-treated adult mice, which are much more resistant to infection as adults than as neonates (B. L. P. Ungar, unpublished data). This suggests the possibility that some T-cell population which is absent in the nude mouse, and which is either CD4-or resistant to the effects of our anti-CD4 antibody, is important in preventing the establishment of severe Cryptosporidium infection but is insufficient to eradicate an already established infection. The occurrence of splenic lymphoid and mesenteric lymph node hyperplasia in most Cryptosporidium sp.-infected nude mice and in mice treated with anti-CD4 plus anti-CD8 antibodies suggests that non-T cells in these mice respond immunologically to Cryptosporidium but that this is not effective in curing the infection. A lack of T cells is crucial to the establishment of persistent Cryptosporidium infection, and reconstitution with a T-cell population that includes CD4+ T cells is necessary for successful recovery from cryptosporidiosis. The animal models of chronic Cryptosporidium infection described here will be useful for the further definition of defects in the immune response to Cryptosporidium sp. that might be amenable to immunotherapy, as well as for assessment of potential prophylactic and treatment modalities.
